Anika Therapeutics (ANIK) EBITDA Margin Growth (5y) (2015 - 2026)
Anika Therapeutics (ANIK) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Anika Therapeutics | 285.40 Mn | 246.98 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,501.00 |
| Mar 31, 2026 | -2,220.00 |
| Dec 31, 2025 | 5,703.00 |
| Sep 30, 2025 | 1,339.00 |
| Jun 30, 2025 | 1,627.00 |
| Mar 31, 2025 | -3,641.00 |
| Dec 31, 2024 | -1,843.00 |
| Sep 30, 2024 | -4,085.00 |
| Jun 30, 2024 | -4,506.00 |
| Mar 31, 2024 | -3,081.00 |
| Dec 31, 2023 | -88,830.00 |
| Sep 30, 2023 | -5,051.00 |
| Jun 30, 2023 | -4,501.00 |
| Mar 31, 2023 | 373.00 |
| Dec 31, 2022 | -62,166.00 |
| Sep 30, 2022 | -5,218.00 |
| Jun 30, 2022 | -6,150.00 |
| Mar 31, 2022 | -4,392.00 |
| Dec 31, 2021 | -6,982.00 |
| Sep 30, 2021 | -4,979.00 |